Angiogenesis, the formation of new blood vessels, is a tightly regulated function determined by the local balance of endogenous angiogenesis stimulators versus inhibitors. The central hypothesis for this proposal is that the angiogenic balance varies between individuals and that this variation is in large part genetically determined. Indeed, epidemiological data suggests that different racial populations have varied susceptibility to ocular neovascularization. We have surveyed inbred mouse strains to see if mice have a range of angiogenic diversity that models that of humans. Using the corneal micro pocket neovascularization assay, we have observed a greater than ten-fold difference in responsiveness to either basic fibroblast growth factor (bFGF) or vascular endothelial growth factor (VEGF) among various mouse strains. The inheritance pattern observed for these traits supported a QTL (quantitative trait locus) approach to mapping the genes responsible for the differences in angiogenic responsiveness. To overcome variability in the assay, we used recombinant inbred lines to map this phenotype. In BXD (C57BL/6J x DBA/2J) mice, we have mapped the regions responsible for regulating VEGF and bFGF induced angiogenesis. VEGF responsiveness is associated with regions on chromosomes 2 and 10, while bFGF responsiveness is associated with regions on chromosomes 4, 13, 15 and 18. We now propose to confirm these areas of linkage by testing the phenotype in congenic and consomic mice that have been bred to isolate each of the above linked DBA/2J areas onto a C57BL/6J genetic background. We are also mapping the phenotype in a different set of recombinant inbred mice known as AXB (A/J x C57BL/6J) to confirm overlapping associated areas. Next we will refine our linked regions by performing fine mapping. Lastly, we plan to identify and screen candidate genes in our strongest linked regions by utilizing the Celera mouse SNP database. Candidate genes will then be validated by a variety of methods.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY012726-09
Application #
7385920
Study Section
Special Emphasis Panel (ZRG1-AED (01))
Program Officer
Chin, Hemin R
Project Start
1999-08-01
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2010-03-31
Support Year
9
Fiscal Year
2008
Total Cost
$402,056
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Khajavi, Mehrdad; Zhou, Yi; Birsner, Amy E et al. (2017) Identification of Padi2 as a novel angiogenesis-regulating gene by genome association studies in mice. PLoS Genet 13:e1006848
Adini, Irit; Adini, Avner; Bazinet, Lauren et al. (2015) Melanocyte pigmentation inversely correlates with MCP-1 production and angiogenesis-inducing potential. FASEB J 29:662-70
Adini, Irit; Ghosh, Kaustabh (2015) Mouse Retinal Whole Mounts and Quantification of Vasculature Protocol. Bio Protoc 5:
Adini, Irit; Ghosh, Kaustabh; Adini, Avner et al. (2014) Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment. J Clin Invest 124:425-36
Rogers, Michael S; Adini, Irit; McBride, Aaron F et al. (2013) The albino mutation of tyrosinase alters ocular angiogenic responsiveness. Angiogenesis 16:639-46
Rogers, Michael S; Boyartchuk, Victor; Rohan, Richard M et al. (2012) The classical pink-eyed dilution mutation affects angiogenic responsiveness. PLoS One 7:e35237
Rogers, Michael S; D'Amato, Robert J (2012) Common polymorphisms in angiogenesis. Cold Spring Harb Perspect Med 2:
Nakai, Kei; Rogers, Michael S; Baba, Takashi et al. (2009) Genetic loci that control the size of laser-induced choroidal neovascularization. FASEB J 23:2235-43
Pakneshan, Pouya; Birsner, Amy E; Adini, Irit et al. (2008) Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs. Invest Ophthalmol Vis Sci 49:3909-13
Shaked, Yuval; Bertolini, Francesco; Man, Shan et al. (2005) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 7:101-11

Showing the most recent 10 out of 11 publications